The window of opportunity for administration of magnesium therapy following focal brain injury is 24 h but is task dependent in the rat

Michael R. Hoane, Timothy M. Barth

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The present study was conducted to establish the window of opportunity for the administration of a regimen of MgCl2 pharmacotherapy following focal injury to the brain. Rats were subjected to unilateral electrolytic lesions of the sensorimotor cortex (SMC) and administered a regimen of MgCl2 (1.0 mmol/kg) or 0.9% saline (1.0 ml/kg) beginning either 15 min, 8 h or 24 h after injury. Subsequent injections were administered 24 and 72 h after the initial treatment. Behavioral testing assessed recovery of function on several sensorimotor behaviors for 24 days following injury. The results of the present study suggest that treatment with a regimen of MgCl2 significantly facilitated recovery of function on the forelimb→forelimb and vibrissae→forelimb placing tests when administered 15 min, 8 h or 24 h after injury compared with saline-treated rats. Recovery of locomotor placing was significantly facilitated at 15 min and 8 h but not at 24 h compared with saline-treated rats. In addition, the ability of MgCl2 to limit neuronal loss in the ipsilateral ventral posterior lateral (VPL) nucleus of the thalamus was seen at only the 15-min treatment interval. These results suggest that the window of opportunity for MgCl2 pharmacotherapy is 24 h, task dependent and is much shorter for protecting neurons in the VPL.

Original languageEnglish (US)
Pages (from-to)271-280
Number of pages10
JournalPhysiology and Behavior
Volume76
Issue number2
DOIs
StatePublished - Jun 1 2002

Fingerprint

Magnesium Chloride
Brain Injuries
Magnesium
Ventral Thalamic Nuclei
Recovery of Function
Wounds and Injuries
Posterior Thalamic Nuclei
Lateral Thalamic Nuclei
Therapeutics
Drug Therapy
Aptitude
Neurons
Injections

Keywords

  • Brain injury
  • Cortex
  • Magnesium chloride
  • Rat
  • Recovery of function
  • Sensorimotor behavior
  • Window of opportunity

ASJC Scopus subject areas

  • Experimental and Cognitive Psychology
  • Behavioral Neuroscience

Cite this

The window of opportunity for administration of magnesium therapy following focal brain injury is 24 h but is task dependent in the rat. / Hoane, Michael R.; Barth, Timothy M.

In: Physiology and Behavior, Vol. 76, No. 2, 01.06.2002, p. 271-280.

Research output: Contribution to journalArticle

@article{45ec057163974e838fd24f883994f414,
title = "The window of opportunity for administration of magnesium therapy following focal brain injury is 24 h but is task dependent in the rat",
abstract = "The present study was conducted to establish the window of opportunity for the administration of a regimen of MgCl2 pharmacotherapy following focal injury to the brain. Rats were subjected to unilateral electrolytic lesions of the sensorimotor cortex (SMC) and administered a regimen of MgCl2 (1.0 mmol/kg) or 0.9{\%} saline (1.0 ml/kg) beginning either 15 min, 8 h or 24 h after injury. Subsequent injections were administered 24 and 72 h after the initial treatment. Behavioral testing assessed recovery of function on several sensorimotor behaviors for 24 days following injury. The results of the present study suggest that treatment with a regimen of MgCl2 significantly facilitated recovery of function on the forelimb→forelimb and vibrissae→forelimb placing tests when administered 15 min, 8 h or 24 h after injury compared with saline-treated rats. Recovery of locomotor placing was significantly facilitated at 15 min and 8 h but not at 24 h compared with saline-treated rats. In addition, the ability of MgCl2 to limit neuronal loss in the ipsilateral ventral posterior lateral (VPL) nucleus of the thalamus was seen at only the 15-min treatment interval. These results suggest that the window of opportunity for MgCl2 pharmacotherapy is 24 h, task dependent and is much shorter for protecting neurons in the VPL.",
keywords = "Brain injury, Cortex, Magnesium chloride, Rat, Recovery of function, Sensorimotor behavior, Window of opportunity",
author = "Hoane, {Michael R.} and Barth, {Timothy M.}",
year = "2002",
month = "6",
day = "1",
doi = "10.1016/S0031-9384(02)00714-X",
language = "English (US)",
volume = "76",
pages = "271--280",
journal = "Physiology and Behavior",
issn = "0031-9384",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - The window of opportunity for administration of magnesium therapy following focal brain injury is 24 h but is task dependent in the rat

AU - Hoane, Michael R.

AU - Barth, Timothy M.

PY - 2002/6/1

Y1 - 2002/6/1

N2 - The present study was conducted to establish the window of opportunity for the administration of a regimen of MgCl2 pharmacotherapy following focal injury to the brain. Rats were subjected to unilateral electrolytic lesions of the sensorimotor cortex (SMC) and administered a regimen of MgCl2 (1.0 mmol/kg) or 0.9% saline (1.0 ml/kg) beginning either 15 min, 8 h or 24 h after injury. Subsequent injections were administered 24 and 72 h after the initial treatment. Behavioral testing assessed recovery of function on several sensorimotor behaviors for 24 days following injury. The results of the present study suggest that treatment with a regimen of MgCl2 significantly facilitated recovery of function on the forelimb→forelimb and vibrissae→forelimb placing tests when administered 15 min, 8 h or 24 h after injury compared with saline-treated rats. Recovery of locomotor placing was significantly facilitated at 15 min and 8 h but not at 24 h compared with saline-treated rats. In addition, the ability of MgCl2 to limit neuronal loss in the ipsilateral ventral posterior lateral (VPL) nucleus of the thalamus was seen at only the 15-min treatment interval. These results suggest that the window of opportunity for MgCl2 pharmacotherapy is 24 h, task dependent and is much shorter for protecting neurons in the VPL.

AB - The present study was conducted to establish the window of opportunity for the administration of a regimen of MgCl2 pharmacotherapy following focal injury to the brain. Rats were subjected to unilateral electrolytic lesions of the sensorimotor cortex (SMC) and administered a regimen of MgCl2 (1.0 mmol/kg) or 0.9% saline (1.0 ml/kg) beginning either 15 min, 8 h or 24 h after injury. Subsequent injections were administered 24 and 72 h after the initial treatment. Behavioral testing assessed recovery of function on several sensorimotor behaviors for 24 days following injury. The results of the present study suggest that treatment with a regimen of MgCl2 significantly facilitated recovery of function on the forelimb→forelimb and vibrissae→forelimb placing tests when administered 15 min, 8 h or 24 h after injury compared with saline-treated rats. Recovery of locomotor placing was significantly facilitated at 15 min and 8 h but not at 24 h compared with saline-treated rats. In addition, the ability of MgCl2 to limit neuronal loss in the ipsilateral ventral posterior lateral (VPL) nucleus of the thalamus was seen at only the 15-min treatment interval. These results suggest that the window of opportunity for MgCl2 pharmacotherapy is 24 h, task dependent and is much shorter for protecting neurons in the VPL.

KW - Brain injury

KW - Cortex

KW - Magnesium chloride

KW - Rat

KW - Recovery of function

KW - Sensorimotor behavior

KW - Window of opportunity

UR - http://www.scopus.com/inward/record.url?scp=0036606178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036606178&partnerID=8YFLogxK

U2 - 10.1016/S0031-9384(02)00714-X

DO - 10.1016/S0031-9384(02)00714-X

M3 - Article

C2 - 12044600

AN - SCOPUS:0036606178

VL - 76

SP - 271

EP - 280

JO - Physiology and Behavior

JF - Physiology and Behavior

SN - 0031-9384

IS - 2

ER -